Genetics Research On Host Responses To HIV May Lead To Improved Therapies And A Vaccine
Jul 24th 2007Drug InformationGenetics
The first genome-wide association study of an infectious disease, conducted by an international group of researchers through the Center for HIV/AIDS Vaccine Immunology (CHAVI), has yielded a new understanding of why some people can suppress virus levels following HIV infection. “The clearer picture of host responses to the virus achieved through this examination of genomes could lead to improved HIV therapies and provides new targets for vaccine developers,” says Elias A. Zerhouni, M.D. [click link for full article]
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
